Inotek Pharma - Company & Market Research Reports

Inotek Pharmaceuticals is a clinical-stage biopharmaceutical company based in Lexington, Massachusetts. It is focused on the development and commercialization of therapies for glaucoma and other serious diseases of the eye. The company's lead product candidate is Trabodenoson, formerly known as INO-8875, which is in Phase III clinical trials for lowering IOP. Trabodenoson has completed Phase 1, 2, and 3 clinical trials in subjects with OHT and POAG. Inotek was founded in 1999.


Novel Drugs and Devices to Lower Intraocular Pressure, 2016 - 2026 - Product Thumbnail Image

Novel Drugs and Devices to Lower Intraocular Pressure, 2016 - 2026

  • Report
  • 228 Pages
From
Global Glaucoma Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025 - Product Thumbnail Image

Global Glaucoma Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • Report
From
Global Glaucoma Treatment Drugs Market Forecast to 2020 - New Product Launches Expected to Boost Market - Product Thumbnail Image

Global Glaucoma Treatment Drugs Market Forecast to 2020 - New Product Launches Expected to Boost Market

  • Report
  • 150 Pages
From
Ocular Disorders: Rising Therapeutics, Technologies, and Devices - Overview  - Product Thumbnail Image

Ocular Disorders: Rising Therapeutics, Technologies, and Devices - Overview

  • Report
  • 208 Pages
From
Open-Angle Glaucoma - Pipeline Review, H2 2016 - Product Thumbnail Image

Open-Angle Glaucoma - Pipeline Review, H2 2016

  • Report
  • 123 Pages
From
Open-Angle Glaucoma - Pipeline Review, H1 2016 - Product Thumbnail Image

Open-Angle Glaucoma - Pipeline Review, H1 2016

  • Report
  • 121 Pages
From
Open-Angle Glaucoma - Pipeline Review, H2 2015 - Product Thumbnail Image

Open-Angle Glaucoma - Pipeline Review, H2 2015

  • Report
  • 94 Pages
From
Open-Angle Glaucoma - Pipeline Review, H1 2015 - Product Thumbnail Image

Open-Angle Glaucoma - Pipeline Review, H1 2015

  • Report
  • 86 Pages
From
The 2018-2023 World Outlook for Glaucoma Pharmaceuticals - Product Thumbnail Image

The 2018-2023 World Outlook for Glaucoma Pharmaceuticals

  • Report
  • 292 Pages
Optic Neuropathy Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Optic Neuropathy Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • 59 Pages
From
Glaucoma Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Glaucoma Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 586 Pages
From
Contrast Induced Nephropathy Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Contrast Induced Nephropathy Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 108 Pages
From
Retinal Degeneration Global Clinical Trials Review, H2, 2016 - Product Thumbnail Image

Retinal Degeneration Global Clinical Trials Review, H2, 2016

  • Clinical Trials
  • 60 Pages
From
Adenosine A1 Receptor Antagonist -Pipeline Insight, 2018 - Product Thumbnail Image

Adenosine A1 Receptor Antagonist -Pipeline Insight, 2018

  • Drug Pipelines
  • 60 Pages
From
Adenosine A1 Receptor Agonist -Pipeline Insight, 2018 - Product Thumbnail Image

Adenosine A1 Receptor Agonist -Pipeline Insight, 2018

  • Drug Pipelines
  • 60 Pages
From
Adenosine A2A Receptor Agonist -Pipeline Insight, 2018 - Product Thumbnail Image

Adenosine A2A Receptor Agonist -Pipeline Insight, 2018

  • Drug Pipelines
  • 60 Pages
From
Adenosine A3 Receptor Agonist -Pipeline Insight, 2018 - Product Thumbnail Image

Adenosine A3 Receptor Agonist -Pipeline Insight, 2018

  • Drug Pipelines
  • 60 Pages
From
Competitor Analysis - Antibody Therapy of Inflammatory and Autoimmune Diseases - Product Thumbnail Image

Competitor Analysis - Antibody Therapy of Inflammatory and Autoimmune Diseases

  • Report
  • 172 Pages
From
The World Cardiovascular Drug Market, (Antihypertensives, Antihyperlipidemics, Vasodilators, Anticoagulants, Diuretics and other Agents) - Product Thumbnail Image

The World Cardiovascular Drug Market, (Antihypertensives, Antihyperlipidemics, Vasodilators, Anticoagulants, Diuretics and other Agents)

  • Report
  • 265 Pages
From
DNA Repair Drugs: Focus on PARP Inhibitors, 2016-2026 - Product Thumbnail Image

DNA Repair Drugs: Focus on PARP Inhibitors, 2016-2026

  • Report
  • 284 Pages
From
Loading Indicator
adroll